Press release
Global Antiretroviral Protease Inhibitor Market Trends, Business Overview, Industry Growth and Forecast to 2022-2028
The global antiretroviral protease inhibitor market is anticipated to grow at a significant CAGR 5% during the forecast period (2022-2028). Proteolysis is the process of breaking down proteins into smaller polypeptides or single amino acids, and a protease is an enzyme molecule that catalyzes this process. A protease inhibitor is a chemical that prevents a protease from working. Antiretroviral protease inhibitors are antiretroviral medications that are used to treat diseases such as HIV. They stop HIV from multiplying by inhibiting the activity of the enzyme HIV protease. Protease inhibitors are being used in a variety of fields. They're utilized as medications to treat diseases such as HIV/AIDS and Hepatitis C, among others.Antiretroviral protease inhibitors are widely used to treat diseases including HIV and HCV. According to the UNAIDS, 37.7 million people across the globe are suffering from the HIV in 2020 and according to the WHO, 58 million people across the globe are suffering from HCV in 2019. Thus, with the rising prevalence of these diseases, the demand for antiretroviral protease inhibitors will further grow during the forecast period.
The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new product launches, in order to stay competitive in the market. For instance-
• In July 2021, Unitaid and CHAI announced a pricing agreement with Hetero Labs LTD, that will boost darunavir with ritonavir (DRV/r) available as second-line therapy for persons living with HIV in low- and middle-income countries for $210 per patient, per year. Darunavir (DRV) in combination with ritonavir is a best-in-class protease inhibitor that has been found to be successful in the treatment of individuals with HIV and has developed multi-drug resistance. DRV is less toxic and easier to take than other protease inhibitors currently used in second-line treatment.
• In June 2021, The USFDA approved Emtricitabine and Tenofovir Disoproxil Fumarate Tablets 200 mg/300 mg of Lupin. Emtricitabine and Tenofovir Disoproxil Fumarate Tablets 200 mg/300 mg are the generic equivalents of Gilead Sciences, Inc's Truvada Tablets 200 mg/300 mg, and are used to treat HIV-1 infection in combination with other antiretroviral drugs.
(Get 15% Discount on Buying this Report)
Get Sample Copy of Global Antiretroviral Protease Inhibitor Market at:
https://orionmarketreports.com/request-sample/?id=102619&submit=Request+Sample%0D%0A
Market Coverage
• The market number available for - 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Mechanism of Action
o By Disease Indication
o By Distribution Channel
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
Competitive Landscape- Janssen Pharmaceuticals Company Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Merck & Co., Inc., AbbVie Inc., and Bristol Myers Squibb, among others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
A full report of Global Antiretroviral Protease Inhibitor Market is available at:
https://orionmarketreports.com/global-antiretroviral-protease-inhibitor-market/102619/
Global Antiretroviral Protease Inhibitor Market Report by Segment
By Mechanism of Action
• Serine Protease Inhibitors
• Cysteine Protease Inhibitors
• Amino Peptidase Inhibitor
• Aspartic Protease Inhibitors
• Metallo-Protease Inhibitors
• Others
By Disease Indication
• HIV/AIDS
• Hepatitis C
• Others
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Global Antiretroviral Protease Inhibitor Market Report by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
Company name: Orion Market Reports
Contact person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
About us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Antiretroviral Protease Inhibitor Market Trends, Business Overview, Industry Growth and Forecast to 2022-2028 here
News-ID: 2611693 • Views: …
More Releases from Orion Market Reports
Sodium Cromoglicate API Market to Expand With Strong Development by 2031
The Sodium Cromoglicate API Market size is expected to grow at an annual average of CAGR 2% during the forecast period (2024-2031). Sodium Cromoglicate API (active pharmaceutical ingredient) is a type of medication used to treat allergic conditions such as hay fever, allergic conjunctivitis, and asthma. It works by stabilizing mast cells and preventing the release of allergic substances that cause symptoms like itching, redness, and swelling.
Sodium Cromoglicate API Market…
Soda Ash and Aluminium Trihydrate (ATH) Market Will Generate Record Revenue by 2 …
The Soda Ash and Aluminium Trihydrate (ATH) Market size is expected to grow at an annual average of CAGR 4% during the forecast period (2024-2031). Soda Ash, also known as sodium carbonate, is a white, odorless powder used in manufacturing glass, detergents, chemicals, and other industrial applications. Aluminium Trihydrate (ATH) is a white, non-toxic powder primarily used as a flame retardant in plastics, rubber, and textiles.
Soda Ash and Aluminium Trihydrate…
Single Crystal Silicon Wafers Market Provides Information on Historical Growth, …
The Single Crystal Silicon Wafers Market size is expected to grow at an annual average of CAGR 4% during the forecast period (2024-2031). Single crystal silicon wafers are thin, disc-shaped substrates made from a single crystal of silicon. They are a fundamental component in the semiconductor industry and serve as the foundation for manufacturing integrated circuits (ICs) and other microelectronic devices.
Single Crystal Silicon Wafers Market research analyzes the entire market,…
Silicone For Personal Care Market Growth Drivers, Developments, Technology And F …
The Silicone For Personal Care Market size is expected to grow at an annual average of CAGR 2% during the forecast period (2024-2031). Silicone for personal care refers to the use of silicone-based ingredients and formulations in various cosmetic and personal care products. Silicone compounds are valued in the personal care industry for their unique properties, including their smooth texture, excellent spreadability, water resistance, film-forming ability, and compatibility with skin…
More Releases for HIV
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments
Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV…
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Introduction to Human Immunodeficiency Virus (HIV) Vaccines
1.1 Overview
1.2 Antiquity of HIV Vaccine
Need for the Development of HIV Vaccine
Primer of HIV inside the Body
3.1 Inclusion of HIV Virus into the System
3.2 Interaction of HIV with Host
3.3 Eradication of HIV Virus
HIV Vaccine Development Process
4.1 Introduction
…
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways…
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus.
Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral…
